MPH Health Care AG
MPH Health Care AG is a German-based investment firm with a primary focus on the healthcare sector. The company's portfolio includes the production and distribution of medicinal products designed to treat serious illnesses like cancer, HIV, and various other chronic conditions. Beyond pharmaceuticals, it also delivers…
Company description based on the data provider's company data, AI-assisted, created on 15/10/2026. Not investment advice.
1D
+1.1%
1W
+1.8%
1M
+4.1%
6M
+43.1%
YTD
+28.2%
1Y
+55.4%
2Y
+14.6%
5Y
+20.5%
10Y
-12.4%
Next earnings date
29/04/2027 (in 194 days)
Volatility around earnings
~10% stronger price swings than usual
P/E
1.13
P/B
0.49
EV/EBITDA
1.2
RETURN ON EQUITY
2.0%
NET MARGIN
4,504.7%
DEBT/EQUITY
0.06
DIVIDEND YIELD
17.7%
AS OF
30/06/2026
FREE FLOAT
40.0%
FLOAT SHARES
1,712,552
AVG. DAILY VOLUME (30D)
1,588
MPH Health Care AG is a company in the Financial Services sector, Asset Management industry, headquartered in Germany.
The CEO is Patrick Brenske, the company employs around 2 people.
The IPO was on 16/05/2011; the stock trades on XETRA under the ticker 93M1.DE.
The next earnings date is 29/04/2027.
Around past earnings, price swings were roughly 10% stronger than usual.
Yes. The last dividend was €5.00 per share, ex-date 10/07/2026, paid on 14/07/2026.
The dividend yield is 17.7% (as of 30/06/2026).
Comparable stocks include DWS Group GmbH, MLP, BlackRock, Blackstone, KKR &, Apollo Global Management, State Street and Ameriprise Financial.
Clicking "Analyze stock" lets five strategies assess MPH Health Care against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.